Gavi, the Vaccine Alliance

Company

Investment-firm

Last deal

$1B

Amount

Debt Financing

Stage

16.05.2022

Date

1

all rounds

$1B

Total amount

Financing round

General

About Company
Gavi, the Vaccine Alliance, helps vaccinate children against deadly diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2000

Number of employees

Company Type

For Profit

Last funding type

Debt Financing

IPO status

Private

Description

Gavi, established in 2000, is a global Vaccine Alliance that brings together public and private sectors to ensure equal access to vaccines for children in the world's poorest countries. By immunizing over 888 million children and preventing 15 million future deaths, Gavi has significantly reduced child mortality in 73 lower-income countries. As a co-convener of the COVAX Facility, Gavi is working alongside other organizations to ensure equitable access to COVID-19 vaccines worldwide. Through their efforts, Gavi is transforming lives, boosting economies, and making the world safer for everyone.
Contacts

Contact Email

Phone number

Social url

Similar Companies
998
Sabin Vaccine Institute

Sabin Vaccine Institute

The company develops vaccines to prevent diseases and improve global healthcare.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Biotechnology, Medical

Location

Washington Cir NW, Washington, DC, USA

total rounds

3

total raised

$63.1M
Coalition for Epidemic Preparedness Innovations

Coalition for Epidemic Preparedness Innovations

CEPI is a non-profit alliance developing vaccines against future epidemics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

Washington Cir NW, Washington, DC, USA

count Of Investments

22

count Of Exists

2
European League Against Rheumatism

European League Against Rheumatism

EULAR is a non-profit organisation that facilitates and stimulates research projects in rheumatic diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Non-Profit, Association

Location

Kilchberg, 72072 Tübingen, Germany
CACNA1A Foundation

CACNA1A Foundation

The CACNA1A Foundation accelerates research for CACNA1A-linked diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Non-Profit, Medical

Financials

Funding Rounds
1
1

Number of Funding Rounds

$1B

Money Raised

Their latest funding was raised on 16.05.2022. Their latest investor U.S. International Development Finance Corp. Their latest round Debt Financing

Date 
Funding Round 
Investors 
Money Raised 
Lead 
U.S. International Development Finance Corp

U.S. International Development Finance Corp

The DFC is a government development bank that partners with the private sector to finance solutions for developing countries.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Government, Finance

Location

Washington Cir NW, Washington, DC, USA

count Of Investments

95

count Of Exists

1
Investments
1
Date 
name 
Lead 
type 
Raised 
Merck Sharp & Dohme Sweden AB

Merck Sharp & Dohme Sweden AB

Merck is a biopharmaceutical company that develops and provides innovative medicines and vaccines to save and improve lives globally.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Kenilworth, NJ, USA

total rounds

2

total raised

$5.59M

count Of Investments

21

count Of Exists

4
Co-Investors
Investors
1
1

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
U.S. International Development Finance Corp

U.S. International Development Finance Corp

The DFC is a government development bank that partners with the private sector to finance solutions for developing countries.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Government, Finance

Location

Washington Cir NW, Washington, DC, USA

count Of Investments

95

count Of Exists

1

Scott Nathan

Scott Nathan CEO of the US International Development Finance Corporation.

current job

U.S. International Development Finance Corp
U.S. International Development Finance Corp

People

Employee Profiles
47

Lizna Makhani

Senior analyst

Oliver Cann

Oliver Cann

Director Of Communications

Mariabruna Jennings

Intern

Clara Maure

Project officer, focal point for francophone africa, partners' engagement framework

Sophie Brivady

Human resources business partner

Yoshinobu Nagamine

Senior manager

Pascal Bijleveld

Director, country support

Ricard Lacort

Senior country manager

Activity

Recent News
51
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week